Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2024-01-01
2024-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. a text message-based screening, phone-based brief intervention, and referral to treatment by a remote care coordinator (m-SBIRT; intervention arm), versus
2. evidence-based, in-person Screening, Brief Intervention, and Referral to Treatment (SBIRT; Treatment As Usual (TAU); control arm).
Primary Aim is to compare the efficacy of m-SBIRT to TAU in positive screens for substance use. Secondary Aim is to compare m-SBIRT to TAU on Substance Use Treatment Attendance.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrating Substance Abuse Assessment & Intervention in Primary Care Settings
NCT01751672
Technologically-Augmented Referrals to Mitigate Addiction Consequences
NCT04401215
Multiple Behavior Screening, Brief Intervention and Referral to Treatment (SBIRT) Model of Drug Abuse in Primary Care
NCT01439334
Computerized Screening, Brief Intervention, and Referral to Treatment in Primary Care
NCT01003834
Remote Brief Intervention and Referrals to Treatment Service for Alcohol
NCT02622984
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment as Usual
This group will receive routine substance use screening questions during their in-person primary care visit as part of standard of care.
No interventions assigned to this group
m-SBIRT (mobile-Screening, Brief Intervention, and Referral to Treatment)
This group will receive a mobile phone text message based substance use screening (questions used in standard of care) with immediate automated feedback, paired with remote care coordination and, if appropriate, referral to substance use disorder (SUD) treatment.
m-SBIRT (mobile-Screening, Brief Intervention, and Referral to Treatment)
M-SBIRT is a mobile phone-based program designed to enhance delivery of Screening, Brief Intervention, and Referral to Treatment (SBIRT), an evidence-based approach for mental health and substance use screening and treatment. The program utilizes mobile phone text message-based screenings with immediate automated feedback, paired with remote care coordination and, if appropriate, referral to substance use disorder treatment services.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
m-SBIRT (mobile-Screening, Brief Intervention, and Referral to Treatment)
M-SBIRT is a mobile phone-based program designed to enhance delivery of Screening, Brief Intervention, and Referral to Treatment (SBIRT), an evidence-based approach for mental health and substance use screening and treatment. The program utilizes mobile phone text message-based screenings with immediate automated feedback, paired with remote care coordination and, if appropriate, referral to substance use disorder treatment services.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Attended a primary care visit at the MUSC Family Medicine clinic on Bee St
* English fluency
* Owner of a cell phone with SMS text-message based capability
* Access to WIFI
* A device to allow audio and video teleconferencing if completing informed consent remotely
* Able to provide informed consent.
Exclusion Criteria
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Constance Guille, MD
Role: PRINCIPAL_INVESTIGATOR
Professor-Faculty
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00133783
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.